Influenza A H1N1 Intranasal Vaccine
FDA Approves New Seasonal Flu Vaccine Made Using Novel Technology »
"The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the preve"...
Read the FDA Approves New Seasonal Flu Vaccine Made Using Novel Technology article »
Influenza A H1N1 Intranasal Vaccine
INDICATIONS
Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is indicated for the active immunization of individuals 2-49 years of age against influenza disease caused by pandemic (H1N1) 2009 virus.
DOSAGE AND ADMINISTRATION
FOR INTRANASAL ADMINISTRATION BY A HEALTH CARE PROVIDER.
Dosing Information
Clinical studies are ongoing with Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal to determine the optimal number of doses.
Available data show that children 9 years of age and younger are largely serologically naïve to the pandemic (H1N1) 2009 virus [1]. Based upon these data Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal should be administered as follows:
| Age Group | Dosage Schedule |
| Children age 2 years through 9 years | 2 doses (0.2 mL* each, approximately 1 month apart) |
| Children, adolescents and adults age 10 through 49 years | 1 dose (0.2 mL*) |
| * Administer as 0.1 mL per nostril. | |
Each 0.2 mL dose is administered as 0.1 mL per nostril.
Administration Instructions
Each sprayer contains a single dose; approximately one-half of the contents should be administered into each nostril. Refer to the administration diagram (Figure 1) for step-by-step administration instructions. Once the vaccine has been administered, the sprayer should be disposed of according to the standard procedures for medical waste (e.g., sharps container or biohazard container).
Figure 1
 |
Note: Active inhalation (i.e., sniffing) is not required by the patient during vaccine administration
HOW SUPPLIED
Dosage Forms And Strengths
Pre-filled, single-dose intranasal sprayer containing 0.2 mL suspension [See DESCRIPTION].
Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is supplied for intranasal delivery in a package of 10 pre-filled, single-use sprayers.
NDC 66019-200-10
Storage and Handling
Once Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal has been administered, the sprayer should be disposed of according to the standard procedures for medical waste (e.g., sharps container or biohazard container).
INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE LIVE, INTRANASAL SHOULD BE STORED IN A REFRIGERATOR BETWEEN 2-8°C (35-46°F) UPON RECEIPT AND UNTIL USE. THE PRODUCT MUST BE USED BEFORE THE EXPIRATION DATE ON THE SPRAYER LABEL.
DO NOT FREEZE.
The cold chain (2 to 8°C) must be maintained when transporting Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal.
Manufactured by: MedImmune, LLC Gaithersburg, MD 20878. 1-877-633-4411. Issue Date: September 2009
Last reviewed on RxList: 11/5/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Influenza A H1N1 Intranasal Vaccine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
